2.5. Cell Viability and Proliferation

LJ Luna Jiménez-Castilla
GM Gema Marín-Royo
MO Macarena Orejudo
LO Lucas Opazo-Ríos
TC Teresa Caro-Ordieres
IA Inés Artaiz
TS Tatiana Suárez-Cortés
AZ Arturo Zazpe
GH Gonzalo Hernández
CG Carmen Gómez-Guerrero
JE Jesús Egido
ask Ask a question
Favorite

Cell viability was measured by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide tetrazolium (MTT) colorimetric assay (M-5655, Sigma-Aldrich). Briefly, HK2 cells were plated in 96-well plates (1.5 × 104 cells/well) in RPMI with 10% FBS, synchronized overnight in serum-free medium, and then incubated in triplicate in medium containing hidrosmin, vehicle, 10% FBS (positive control), and 10% DMSO (negative control) for additional 24, 48 and 72 h. After treatment, the MTT solution (0.5 mg/mL) was added for 90 min, and the absorbance of the metabolized MTT was measured at λ = 570 nm in a plate reader.

For cell proliferation assay at 24, 48, and 72 h, HK2 cells were seeded onto 96-well plates at densities of 2 × 104, 1 × 104, and 5 × 103 cells/well, respectively, then synchronized overnight in serum-free medium and incubated in triplicate in RPMI with 10% FBS containing hidrosmin or vehicle, using 20% FBS and 10% DMSO as positive and negative controls, respectively. After treatment, the 5-bromo-2′-deoxyuridine (BrdU) solution was added during the last 2 h, and cells were processed according to the instructions of the BrdU Cell Proliferation ELISA Kit (ab126556, Abcam).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A